144 related articles for article (PubMed ID: 36847619)
1. Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.
Abalo-Lojo JM; Ferreiro PV; Asorey MK; Colmenero AE; Gonzalez F
Turk J Ophthalmol; 2023 Feb; 53(1):8-12. PubMed ID: 36847619
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
[TBL] [Abstract][Full Text] [Related]
4. Shortening of interpupillary distance after topical prostaglandin analog eye drop application in an ophthalmic surgeon: A case report.
Sano I; Takahashi H; Hara T; Kawashima H; Mayama C
Am J Ophthalmol Case Rep; 2022 Jun; 26():101480. PubMed ID: 35313469
[TBL] [Abstract][Full Text] [Related]
5. Periorbital changes associated with prostaglandin analogs in Korean patients.
Kim HW; Choi YJ; Lee KW; Lee MJ
BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma.
Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
J Ocul Pharmacol Ther; 2023; 39(1):63-69. PubMed ID: 36318495
[No Abstract] [Full Text] [Related]
7. Lower Eyelid Horizontal Tightening in Prostaglandin Associated Periorbitopathy.
Procianoy F; P L Lang M; J L Bocaccio F
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S76-S79. PubMed ID: 32890116
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management.
Joganathan V; Cannon PS; Mercieca K
Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370
[TBL] [Abstract][Full Text] [Related]
9. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
Inoue K; Shiokawa M; Wakakura M; Tomita G
J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
[TBL] [Abstract][Full Text] [Related]
10. Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy.
Skorin L; Dailey KH
Optom Vis Sci; 2016 Jul; 93(7):779-81. PubMed ID: 27055061
[TBL] [Abstract][Full Text] [Related]
11. Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.
Sakata R; Shirato S; Miyata K; Aihara M
Eye (Lond); 2014 Dec; 28(12):1446-51. PubMed ID: 25233818
[TBL] [Abstract][Full Text] [Related]
12. Periocular mexametric melanin and erythema indexes in adult glaucoma patients treated with topical prostaglandin analogs.
Duman N; Duman R; Yavaş GF; Doğruk Kaçar S; Özuğuz P; Çetinkaya E
Cutan Ocul Toxicol; 2017 Mar; 36(1):9-11. PubMed ID: 26911512
[TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin-associated periorbitopathy].
Zhang F; Liao S; Liu K; Duan XC
Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):637-640. PubMed ID: 28851204
[TBL] [Abstract][Full Text] [Related]
14. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
[TBL] [Abstract][Full Text] [Related]
15. Latanoprost-induced prostaglandin-associated periorbitopathy.
Tan J; Berke S
Optom Vis Sci; 2013 Sep; 90(9):e245-7; discussion 1029. PubMed ID: 23912967
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin-associated periorbitopathy in latanoprost users.
Nakakura S; Yamamoto M; Terao E; Nagatomi N; Matsuo N; Fujisawa Y; Fujio Y; Tabuchi H; Kiuchi Y
Clin Ophthalmol; 2015; 9():51-6. PubMed ID: 25565768
[TBL] [Abstract][Full Text] [Related]
17. Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?
Jamison A; Okafor L; Ullrich K; Schiedler V; Malhotra R
Aesthet Surg J; 2022 Oct; 42(11):1241-1249. PubMed ID: 35700523
[TBL] [Abstract][Full Text] [Related]
18. Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.
Sakata R; Shirato S; Miyata K; Aihara M
Jpn J Ophthalmol; 2014 Mar; 58(2):212-7. PubMed ID: 24390604
[TBL] [Abstract][Full Text] [Related]
19. Periorbital muscle atrophy associated with topical bimatoprost therapy.
Wang PX; Koh VT; Cheng JF
Clin Ophthalmol; 2014; 8():311-4. PubMed ID: 24511225
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need.
Sakata R; Chang PY; Sung KR; Kim TW; Wang TH; Perera SA; Cantor LB
Semin Ophthalmol; 2022 May; 37(4):447-454. PubMed ID: 34793279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
